1. Home
  2. CRMT vs HOWL Comparison

CRMT vs HOWL Comparison

Compare CRMT & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$2.11

Market Cap

19.7M

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.35

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
HOWL
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
18.9M
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
CRMT
HOWL
Price
$2.11
$0.35
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$29.50
$5.00
AVG Volume (30 Days)
946.4K
587.2K
Earning Date
06-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
147.36
18.40
EPS
N/A
N/A
Revenue
$1,390,932,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$0.34
52 Week High
$62.55
$2.23

Technical Indicators

Market Signals
Indicator
CRMT
HOWL
Relative Strength Index (RSI) 21.83 29.14
Support Level $1.38 N/A
Resistance Level $13.68 $0.74
Average True Range (ATR) 1.49 0.04
MACD -0.43 0.01
Stochastic Oscillator 6.98 3.24

Price Performance

Historical Comparison
CRMT
HOWL

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: